Medical Science Liaison; MSL – Solid Tumors; Endometrial Cancer - West Coast; Fully Remote

• Serve as Karyopharm’s field-based scientific expert supporting the endometrial cancer program and broader solid tumor strategy.
• Build relationships with gynecologic oncologists, medical oncologists, investigators, academic centers, and community oncology practices.
• Facilitate the compliant exchange of scientific information and gather meaningful insights for development and launch planning.

Candidate Profile & Requirements:

• Advanced doctoral degree preferred (Pharm
  
  D, MD, DO, PhD); candidates with significant oncology MSL experience considered.
• 3+ years of oncology MSL experience required; solid tumor experience required.
• Strong scientific communication and presentation skills; ability to travel up to 75%.

Our Value Proposition:

• Pioneering nuclear export inhibition to develop differentiated therapies for cancer patients.
• Building upon an established commercial foundation in multiple myeloma while advancing selinexor across additional cancers.
• Opportunity to help shape what comes next in a collaborative, fast-moving environment where individual contributions are visible and valued.

Karyopharm Therapeutics is pioneering the science of nuclear export inhibition to develop differentiated therapies for cancer patients. The company has an established commercial foundation in multiple myeloma and is advancing selinexor across hematologic and solid tumors, with a collaborative, fast-moving environment where individual contributions are valued.